Clinical trial · Observational
Investigating Memory and Physical Activity After Cancer Treatment in Survivors of Adolescent and Young Adult Cancers
NCT06880861CI-TRIAL-00120431IMPACTrecruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study evaluates relationships among physical activity, thinking, and memory after cancer treatment in survivors of adolescent and young adult cancers.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Hematopoietic and Lymphatic System Neoplasm | Hematopoietic and Lymphatic System Neoplasm | ONTOLOGY_EXACT | 0.98 |
| Malignant Solid Neoplasm | Malignant Solid Neoplasm | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Non-Interventional Study | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Observational
- description
- Patients complete questionnaires and cognitive tasks and wear an activity monitor to measure physical activity on study. Some patients may optionally participate in an interview on study.
- interventionNames
- Other: Non-Interventional Study
Primary outcomes (1)
- measure
- Cognitive performance on Stroop task
- timeFrame
- Up to 4 weeks
- description
- Assessed using the CNS Vital Signs computerized testing platform ("brain games"). CNS Vital Signs is a computerized neuropsychological/neurocognitive assessment platform used by clinicians and researchers to objectively evaluate brain function and neurocognitive status, offering a range of tests and tools for assessment and management of various neurological and behavioral conditions.
Secondary outcomes (9)
- measure
- Cognitive performance on Visual Memory Test
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Adults (aged 18+ years) * Primary diagnosis of cancer when 15-39 years-old * Access to a desktop computer or laptop with reliable internet access * No gross motor impairments that prohibit ambulation * Willing to complete study requirements * English speaking Exclusion Criteria: * Diagnosed with nonmelanoma skin cancer only * Not diagnosed with cancer in adolescent and young adult (AYA) age range of 15-39 years * Scheduled travel during the study period that is not indicative of individual's normal schedule
References
Publications (0)
Data not yet available
No reference posted for this study.